生物技术与制药领域的最新动态
Comparative analysis of illumina and oxford nanopore sequencing platforms for 16S rRNA profiling of respiratory microbial communities | Scientific Reports - Nature
Leveraging illumina iSeq100 for whole genome sequencing of Salmonella Typhi for a resource-limited setting - Nature
Illumina to develop KRAS companion diagnostics with multiple pharma partners - FirstWord Pharma
Illumina advances personalized cancer care with new pharma development partnerships - PR Newswire
Illumina sued by rival Element over gene-sequencing technology - Reuters
How an Illumina bioinformatics engineer contributes to the company mission - Illumina
One Year After Illumina/Grail – How Are EU Competition Authorities Now Dealing With Below-Threshold Mergers - Crowell & Moring LLP
Illumina grants and cost-saving options - Illumina
Astrana Health, Privia Health, Illumina, Waters Corporation, and LeMaitre Shares Plummet, What You Need To Know - Yahoo Finance
Illumina® Protein Prep launches to drive greater proteomic insights for improved drug discovery and development - PR Newswire
Illumina begins rolling out protein prep platform ahead of SomaLogic buy - Fierce Biotech
Hardening Software Security: DOJ’s Civil Cyber Fraud Settlements Continue to Illumina[te] the Importance of Cybersecurity - Crowell & Moring LLP
Illumina CEO sees path to stable growth, even as its academic customers face funding uncertainty - statnews.com
Nilesh Shah joins Illumina as Head of Region, AMEA - PR Newswire
Illumina Sees Future Rebound in China Sales - San Diego Business Journal
Direct comparison of clear DX Nanopore and Illumina sequencing of SARS-CoV-2 - ASM Journals
An introduction to the Illumina 5-Base Solution - Illumina
DOJ Secures First of Its Kind Cybersecurity False Claims Act Settlement - White & Case LLP
DOJ reaches $9.8M settlement with Illumina over cyber whistleblower claims - MedTech Dive
Illumina’s SomaLogic acquisition may face GRAIL-like regulatory hurdles - ION Analytics